Systematic ReviewResearchPatient Education

Adverse pregnancy and birth risks rose as ambient heat increased in a large evidence synthesis

Nature communications (PubMed)Aug 21, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

A systematic review and meta-analysis linked increasing ambient heat with higher risk of adverse pregnancy and birth outcomes and modeled temperature thresholds, while substantial heterogeneity limits use of a single universal cutoff.

What NurseJet pulled from the source

The meta-regression included 21 studies with 5,589,862 participants, and the broader narrative synthesis included 103 studies with 41,951,950. Estimated maximum-temperature thresholds rose with modeled risk, but exposure measures varied and the review process lacked independent dual extraction and assessment.

Why this matters for nurses

Pregnant patients may need anticipatory education and access planning during heat events. The synthesis strengthens awareness of heat as a maternal-health risk while warning clinicians not to treat pooled global temperature estimates as universal bedside action thresholds.

Bedside takeaway

Treat heat exposure as a maternal risk factor, but use local alerts and protocols instead of a universal temperature cutoff.

How This Applies in Practice

Use this when: Assessing or educating a pregnant patient during hot weather, a heat alert, or reported occupational or household heat exposure.

On your shift

Ask about recent heat exposure, access to cooling and fluids, exertion, housing or work constraints, and current symptoms.
Reinforce the locally approved heat-safety plan and pregnancy-specific return precautions in clear language.
Escalate concerning maternal or fetal symptoms through the established obstetric triage pathway.

Keep in mind: The pooled estimates are not universal clinical thresholds. Follow local heat guidance, the obstetric protocol, facility policy, and provider orders.

Key takeaways

The threshold meta-regression synthesized 21 studies involving 5,589,862 participants.
The broader narrative synthesis covered 103 studies and 41,951,950 participants.
The authors estimated maximum-temperature thresholds of 30.55°C, 34.11°C, and 39.07°C for modeled 5%, 10%, and 20% increases in adverse-outcome risk.
Heterogeneous exposure indicators and review-method limitations reduce confidence in applying one threshold across locations or patients.

Practice implications

During hot weather or heat alerts, ask about heat exposure, access to cooling and fluids, work or housing constraints, and symptoms using the approved maternal assessment pathway. Reinforce locally authorized heat-safety and return-precaution guidance rather than substituting pooled thresholds for local policy.

Limitations & cautions

Studies used heterogeneous temperature indicators and outcome definitions. The review did not use independent dual data extraction, one reviewer performed quality assessment, and pooled thresholds may not transfer across climates, populations, or individual risk profiles.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Open source

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

Nature communications (PubMed)

Nature communications (PubMed). A systematic review and meta-analysis on heat thresholds for maternal health and birth outcomes.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42624863/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

Journal of midwifery & women's health (PubMed)Sep 7, 2026Research Article

A retrospective analysis of US natality data found no statistically significant yearly difference in neonatal mortality between freestanding birth centers and hospitals among term, singleton, vertex births without major medical risk factors from 2015 through 2024.

L&D / OB PedsAI summaryReview source

Research ArticleResearchPatient EducationAI summary · original source linked below

Adjusted neonatal-mortality odds for freestanding birth centers fluctuated around 1.0 across the 10-year study period. No individual year showed a statistically significant difference from hospital births, including 2020 and 2021 when birth-center volume increased.

Key takeaways

The analysis was restricted to births meeting selected low-risk criteria.
The study found no evidence that higher birth-center use during the pandemic years increased neonatal mortality.
The observational design cannot establish that birth setting itself caused the mortality pattern.

Why this matters on shift

The findings add national outcome data for counseling and systems planning around freestanding birth-center care for appropriately selected low-risk pregnancies.

Bedside takeaway

Apply local eligibility, surveillance, escalation, and transfer protocols when caring for planned low-risk birth-center patients.

Nursing implications

Keep eligibility, surveillance, escalation, and transfer decisions anchored to local birth-center criteria and maternal-newborn protocols.

Limitations & cautions

Abstract-only summary. The study used retrospective vital-record data, was limited to selected low-risk births, and cannot exclude residual differences between people who delivered in birth centers and hospitals.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Journal of midwifery & women's health (PubMed). Neonatal Mortality Risk Among Births in Freestanding Birth Centers, 2015 to 2024.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

The Cochrane database of systematic reviews (PubMed)Sep 4, 2026Systematic Review

An updated Cochrane review found that long-term hormone-therapy risk profiles differed between combined therapy and estrogen-only therapy.

Med-Surg L&D / OBAI summaryReview source

Systematic ReviewResearchMedication SafetyPatient EducationAI summary · original source linked below

The review included 24 randomized, double-blind trials with 45,660 participants. Most participants were postmenopausal, the mean age in most studies exceeded 60 years, and nearly 70% of the data came from HERS and the Women's Health Initiative.

Key takeaways

Combined therapy probably increased breast-cancer risk and may have increased stroke and venous-thromboembolism risk.
Estrogen-only therapy probably increased stroke and gallbladder-surgery risk while reducing clinical fractures.
Findings were driven largely by older oral regimens and may not represent hormone therapy used today.

Why this matters on shift

Medication reconciliation and patient teaching should account for the specific hormone regimen rather than treating all hormone therapy as one exposure.

Bedside takeaway

Confirm the prescribed formulation and promptly communicate new thromboembolic, neurologic, or gallbladder symptoms through the care team.

Nursing implications

Confirm the prescribed formulation and promptly communicate new thromboembolic, neurologic, or gallbladder symptoms through the care team.

Limitations & cautions

Abstract-only summary. The review addressed therapy lasting at least one year, not short-term symptom relief. Most participants were older than the group most likely to seek treatment for vasomotor symptoms.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

The Cochrane database of systematic reviews (PubMed). Long-term hormone therapy for perimenopausal and postmenopausal women.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

The journal of maternal-fetal & neonatal medicine (PubMed)Sep 3, 2026

A meta-analysis linked maternal anemia with preterm birth, but it did not establish that anemia treatment prevents early delivery.

L&D / OBAI summaryReview source

Systematic ReviewResearchAI summary · original source linked below

The review included 45 articles covering 60 study populations and 2,119,392 pregnant individuals. The pooled odds ratio for preterm birth was 1.28 (95% CI 1.20–1.36). Between-study heterogeneity was substantial.

Key takeaways

Heterogeneity was high (I² 95.54%).
The authors identified possible publication bias.
The findings describe an association, not an absolute risk increase or a treatment effect.

Why this matters on shift

This association provides context for discussing anemia within pregnancy risk assessment.

Bedside takeaway

Use this evidence to inform discussion of maternal risk; follow the local anemia screening and treatment pathway.

Nursing implications

Use this evidence to inform discussion of maternal risk; follow the local anemia screening and treatment pathway.

Limitations & cautions

Abstract-only summary. High heterogeneity and potential publication bias limit confidence in a single pooled estimate. This review does not test a specific screening or supplementation strategy.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

The journal of maternal-fetal & neonatal medicine (PubMed). Maternal anemia and the risk of preterm birth: a meta-analysis.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

How This Applies in Practice

Key takeaways

Practice implications

Limitations & cautions

Exact source links

More updates for this clinical area

Low-risk birth-center births showed no higher neonatal mortality in a 10-year analysis

Long-term menopausal hormone therapy has formulation-specific benefits and harms

Maternal anemia was associated with higher odds of preterm birth